| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/25/2010 | WO2010020777A2 Protein expression |
| 02/25/2010 | WO2009148946A3 Cell line, system and method for optical control of secondary messengers |
| 02/25/2010 | WO2009140348A4 Anti-il-6/il-6r antibodies and methods of use thereof |
| 02/25/2010 | WO2005081873A9 Il-13 mutein proteins, antibodies, compositions, methods and uses |
| 02/25/2010 | US20100050293 Improvement of nitrogen responsiveness in plants through the expression of pathways for the formation and catabolism of novel n-rich compounds |
| 02/25/2010 | US20100050292 Galactosyltransferase |
| 02/25/2010 | US20100048878 Human gene |
| 02/25/2010 | US20100048872 Methods for making proteins containing free cysteine residues |
| 02/25/2010 | US20100048868 Polypeptides Having Binding Affinity for Her2 |
| 02/25/2010 | US20100048864 Expression vector comprising nucleotoide sequences coding signal sequences which direct proteins to periplasmic compartment; improving exogenous expression of heterologous polypeptides |
| 02/25/2010 | US20100048689 Process of obtainment of soy isoflavones |
| 02/25/2010 | US20100048485 Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrate |
| 02/25/2010 | US20100048480 Production of anti-microbial peptides |
| 02/25/2010 | US20100048472 Albumin Fusion Proteins |
| 02/25/2010 | US20100048464 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 02/25/2010 | US20100048456 Glycopegylation methods and proteins/peptides produced by the methods |
| 02/25/2010 | US20100047877 polynucleotides encoding the phospholipases; using these enzymes in industrial processes and methods of diagnosing fungal infections; Aspergillus niger; recombinant host cells wherein the expression of a phospholipase is significantly increased or wherein the activity of the phospholipase is increased |
| 02/25/2010 | US20100047873 Process for the production of daptomycin |
| 02/25/2010 | US20100047872 Process for producing useful substance |
| 02/25/2010 | US20100047871 Fusion proteins of hiv regulatory/accessory proteins |
| 02/25/2010 | US20100047870 Low cell density fermentation process for the production of heterologous recombinant proteins in microorganisms |
| 02/25/2010 | US20100047869 Novel Thermophilic Endo-Glucanase and Uses Thereof |
| 02/25/2010 | US20100047868 Tumour Suppressor Protein |
| 02/25/2010 | US20100047867 Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides |
| 02/25/2010 | US20100047866 Heat-Stable Carbonic Anhydrases and Their Use |
| 02/25/2010 | US20100047865 Vector for expressing nc protein of hiv and method for producing nc protein using the same |
| 02/25/2010 | US20100047864 Process for the production of recombinant proteins using carnivorous plants |
| 02/25/2010 | US20100047863 Group of novel enantiosleective microbial nitrile hydratases with broad substrate specificity |
| 02/25/2010 | US20100047862 Novel DNA Polymerase |
| 02/25/2010 | US20100047861 Process for producing useful substance |
| 02/25/2010 | US20100047818 Diagnosis of carcinomas |
| 02/25/2010 | US20100047809 Pca3, pca3 genes, and methods of use |
| 02/25/2010 | US20100047763 Plasmid Expression Vectors for Expression of Recombinant Rotavirus and Astrovirus Proteins or Epitopes |
| 02/25/2010 | US20100047392 Enzymes Having Alpha Amylase Activity and Methods of Making and Using Them |
| 02/25/2010 | US20100047305 Extracellular Matrix Compositions |
| 02/25/2010 | US20100047259 Follistatin domain containing proteins |
| 02/25/2010 | US20100047253 Fully human monoclonal antibodies to il-13 |
| 02/25/2010 | US20100047243 Novel antibodies against igf-ir |
| 02/25/2010 | US20100047239 Dual variable domain immunoglobulin and uses thereof |
| 02/25/2010 | US20100047238 Humanized antibodies against |
| 02/25/2010 | US20100047237 Prevention of aggregation of immunoglobulin light or heavy chains |
| 02/25/2010 | US20100047236 Antibody variants |
| 02/25/2010 | US20100047224 Biosilica-Adhesive Protein Nanocomposite Materials: Synthesis and Application in Dentistry |
| 02/25/2010 | US20100047171 Fusion Proteins That Contain Natural Junctions |
| 02/25/2010 | US20100047170 Peptide Prodrugs |
| 02/25/2010 | US20100047168 Soluble Zcytor 11 Cytokine Receptors |
| 02/25/2010 | US20100047166 Antibodies and related molecules that bind to 58p1d12 proteins |
| 02/25/2010 | CA2734235A1 Methods and compositions for targeted single-stranded cleavage and targeted integration |
| 02/25/2010 | CA2731866A1 Production of cellulase enzymes in plant hosts using transient agroinfiltration |
| 02/24/2010 | EP2157188A1 Method for producing alpha-L-Aspartyl-L-phenylalanine-Beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester |
| 02/24/2010 | EP2157178A1 Antibody against von Willebrand Factor cleaving enzyme and assay system using the same |
| 02/24/2010 | EP2156845A1 Combined vaccines comprising hepatitis B surface antigen and other antigens |
| 02/24/2010 | EP2156844A1 AGENT EXHIBITING PROPERTIES TO FORM THE CELLULAR IMMUNITY AGAINST MYCOBACTERIUM TUBERCULOSIS H37 Rv, METHOD FOR THE PRODUCTION THEREOF (VARIANTS), A RECOMBINANT STRAIN AND AN AGENT FOR TUBERCULOSIS DIAGNOSIS |
| 02/24/2010 | EP2155890A1 Methods of genetically encoding unnatural amino acids in eukaryotic cells using orthogonal trna/synthetase pairs |
| 02/24/2010 | EP2155880A1 Modifying glycoprotein production in plants |
| 02/24/2010 | EP2155865A1 Engineered versions of polysialyltransferases with enhanced enzymatic properties |
| 02/24/2010 | EP2155791A1 Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity |
| 02/24/2010 | EP1485481B1 Fluorescent protein from aequorea coerulescens and uses thereof |
| 02/24/2010 | EP1471936B1 Hiv vaccine and method of use |
| 02/24/2010 | EP1325130B1 Nogo receptor homologs |
| 02/24/2010 | EP1200607B1 Tet repressor-based transcriptional regulatory proteins |
| 02/24/2010 | EP0861261B9 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 02/24/2010 | CN101654693A Method for preparing rapeseed peptides by microorganism fermentation |
| 02/24/2010 | CN101654673A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654672A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654483A compositions and methods for generating chimeric heteromultimers |
| 02/24/2010 | CN101654479A Mammalian receptor proteins, agents, and methods relating thereto |
| 02/24/2010 | CN100591774C Process for manufacture of nematode-extracted anticoagulant protein (NAP) |
| 02/24/2010 | CN100591758C Method for producing target proteins by deleting or amplifying ibpA and/or ibpB gene coding for inclusion body-associated proteins |
| 02/23/2010 | US7668662 Patient-specific dosimetry |
| 02/23/2010 | US7667114 Starch branching enzyme |
| 02/23/2010 | US7667092 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants |
| 02/23/2010 | US7667089 mice, rats, goats, pigs, sheep and cows, whose genome comprises alpha-lactalbumin promoter |
| 02/23/2010 | US7667031 Codons |
| 02/23/2010 | US7667022 Antitubercular agents; expression systems; effective under changing conditions |
| 02/23/2010 | US7667021 Neutralizing human anti-IGFR antibody |
| 02/23/2010 | US7667020 Nucleotide sequence coding receptor protein for detecting moderator of autoimmune disease; treat, prevent, or delay a tissue proliferation-associated disorder as rheumatoid arthritis and multiple sclerosis |
| 02/23/2010 | US7667016 nucleic acid compositions encoding a unique colorless protein, can be photoactivated, used in many biochemical, molecular biological and medical diagnostic applications |
| 02/23/2010 | US7667013 Gene encoding a guanine nucleotide exchange factor and the gene product thereof |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7667006 Anti-HIV antibody |
| 02/23/2010 | US7667005 Polypeptide, novel DNA and novel antibody |
| 02/23/2010 | US7667004 Humanized antibodies against vascular endothelial growth factor |
| 02/23/2010 | US7667000 Antibodies to Zcytor 16 |
| 02/23/2010 | US7666999 Neutral amino acid transporter and gene thereof |
| 02/23/2010 | US7666998 Cell growth inhibitor containing anti-PepT antibody |
| 02/23/2010 | US7666995 Interferons, uses and compositions related thereto |
| 02/23/2010 | US7666994 fusion protein comprising isolated GnRH receptor protein; culturing transformant comprising vector; screening for ligands; cancer and reproductive treatment |
| 02/23/2010 | US7666992 Pancreatic cancer genes |
| 02/23/2010 | US7666837 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
| 02/23/2010 | US7666655 Escherichia bacteria transformed with the yddG gene to enhance L-amino acid producing activity |
| 02/23/2010 | US7666653 Isolated DNA encoding a protein with the amino acid |
| 02/23/2010 | US7666651 Polypeptide having heparanase activity |
| 02/23/2010 | US7666650 Amylase |
| 02/23/2010 | US7666647 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
| 02/23/2010 | US7666642 Nematode fatty acid desaturase-like sequences |
| 02/23/2010 | US7666641 Canine COX-2 proteins and uses thereof |
| 02/23/2010 | US7666640 DNA sequences for the expression of alloproteins |
| 02/23/2010 | US7666634 Fermentation process for the preparation of L-amino acid using modified Escherichia coli wherein the ytfP-yjfA gene region is inactivated |
| 02/23/2010 | US7666633 Enzymes having alpha amylase activity and methods of making and using them |